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The Journal of Immunology
Viral Resistance and IFN Signaling in STAT2 Knockout
Fish Cells
Carola E. Dehler,* Katherine Lester,† Giulia Della Pelle,‡ Luc Jouneau,‡ Armel Houel,‡
Catherine Collins,† Tatiana Dovgan,*,† Radek Machat,‡,1 Jun Zou,*,2 Pierre Boudinot,‡
Samuel A. M. Martin,* and Bertrand Collet†,‡
IFN belong to a group of cytokines specialized in the immunity to viruses. Upon viral infection, type I IFN is produced and alters the
transcriptome of responding cells through induction of a set of IFN stimulated genes (ISGs)with regulatoryor antiviral function, resulting in
a cellular antiviral state. Fish genomes have both type I IFN and type II IFN (IFN-g), but no type III (l) IFN has been identified. Their
receptors are not simple counterparts of the mammalian type I/II IFN receptors, because alternative chains are used in type I IFN
receptors. The mechanisms of the downstream signaling remain partly undefined. In mammals, members of the signal transducer and
activator of family of transcription factors are responsible for the transmission of the signal from cytokine receptors, and STAT2 is
required for type I but not type II IFN signaling. In fish, its role in IFN signaling in fish remains unclear. We isolated a Chinook salmon
(Oncorhynchus tshawytscha) cell line, GS2, with a stat2 gene knocked out by CRISPR/Cas9 genome editing. In this cell line, the induction
of ISGs by stimulation with a recombinant type I IFN is completely obliterated as evidenced by comparative RNA-seq analysis of the
transcriptome of GS2 and its parental counterpart, EC. Despite a complete absence of ISGs induction, the GS2 cell line has a remarkable
ability to resist to viral infections. Therefore, other STAT2-independent pathways may be induced by the viral infection, illustrating the
robustness and redundancy of the innate antiviral defenses in fish. The Journal of Immunology, 2019, 203: 465–475.
I
nterferon is a family of cytokines responsible for driving
antiviral immune processes (1). Upon a viral infection, most
nucleated cells produce type I IFN directing the early antiviral
innate immune response. Specialized immune cells such as
lymphocytes produce type II (g-) IFN, initializing the adaptive
immune response to viruses. Cells respond to IFN through a
signaling process involving specific recognition and activation of
type I, II, and III IFN by specific receptor complexes expressed
at the cell surface: IFNAR1/2–Jak1–Tyk2, IFNGR1/2–Jak1/2,
and IFNlR1/IL–10R2–Jak1/2–Tyk2, respectively (2, 3). The
resulting conformational changes of the receptors create docking
sites for key downstream signaling molecules, the STAT-1 or 2,
that get phosphorylated at specific sites (Y701, S708, S727 for
STAT1 and Y690 for STAT2).
The type I IFN receptor complex docks and phosphorylates
both STAT1 and STAT2, which combine with IFN regulatory
factor (IRF)–9 to form a heterotrimeric complex termed IFN
stimulated gene (ISG) factor 3 (ISGF3) that translocates into
the nucleus and activates IFN-stimulated response elements
(ISRE) within the promoters of a set of ISGs. The ISG consists
of a distinct panel of genes, often with direct antiviral or reg-
ulatory functions responsible for the establishment of an anti-
viral state that blocks viral replication and limits spread of the
virus (4).
In contrast, the type II IFN receptor complex exclusively docks
and phosphorylates STAT1, resulting in the formation of a STAT1/
STAT1 homodimeric complex that translocates into the nucleus and
activates IFN-g activation site (GAS) elements in the genome
resulting in the induction of a GAS-specific set of genes (5). In
fish, functional ISRE and GAS have been identified in promoter of
a discrete number of ISGs (6–8).
The genome of early teleost fish was duplicated 320–350 million
years ago (9) whereas salmonid fish went through an additional
genome duplication event ∼100 million years ago (10–13). Al-
though many genes are lost after a whole genome duplication
event, salmonid IFN and ISG repertoires are complex, with
potentially four paralogous genes for each gene described in
mammals (14, 15).
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Typical genes coding for type I and type II, but not type III, IFN
have been identified in fish genomes. In fact, IFN and many ISG
genes have shown high rates of change during evolutionary time in
fish as in tetrapods, and the number of paralogs can be greatly
expanded or reduced to a single gene. Fish type I IFN genes were
prone to extensive diversification, especially in Salmonids (16), as
is also observed in mammalian genomes (17). Importantly, fish
homologs of the key signaling factors downstream of IFNR, such
as STAT1/2 and IRF9, have been found, indicating that the general
structure of the pathways is probably similar in fish and mammals.
However, several important differences between fish and mam-
malian’s IFN system hamper a straightforward comparison: 1) in
fish, many signaling factors have several paralogs for a unique
counterpart in human or in the mouse, which can lead to sub-
functionalization. Thus, the multiple fish Jak paralogs are not
employed equally for the transmission of the IFN-g signal (18). 2)
Fish type I IFN are divided in two main classes using different
receptors, which have some features in common with components
of the receptors for mammalian type III IFN (18–20), and (3) fish
IFN-g1 and IFN-g2 do not share the same receptor either (18).
Hence, the precise role of the different signaling factors down-
stream of IFN receptors remains unresolved in fish.
STAT proteins are no exceptions to this. They have been de-
scribed as an ancient and highly conserved family, with most
members already defined in the common ancestor of fish and
mammals (15). Also, stat1 and stat2 genes are induced by viral
infections in different fish species, suggesting that they are implicated
in the antiviral response as their homologs in mammals. However,
STATs show varying levels of paralogue retention in salmonids, with
four stat1 copies for only a single stat2 copy. The respective roles of
the different STAT1 and of STAT2 in IFN signaling is therefore still
undefined.
In the current study, we produced a salmonid cell line in which
stat2 has been disrupted using a CRISPR/cas9 based approach. We
used these cells to demonstrate that STAT2 is necessary for the
type I but not type II IFN signaling pathway. The stat2 mutation
resulted in increased production of viral particles of the DNAvirus
epizootic hematopoietic necrosis virus (EHNV) and with the least
extent of the RNAvirus viral hemorrhagic septicemia virus (VHSV).
However, the severe disruption of the type I IFN induced by the
lack of functional STAT2 was not associated with viral hyper-
sensitivity and fast, dramatic cell destruction.
Materials and Methods
Isolation of the GS2 cell line
For generation of the stat2 knockdown cell line, a Chinook salmon
(Oncorhynchus tshawytscha) embryo (CHSE) cell line that was previously
modified to stably express both a monomeric enhanced green fluorescence
protein (mEGFP) and Cas9 (CHSE-EC) was chosen as the starting point of
this study, further referred to as EC (21). The whole genomes of two
different Oncorhynchus species (Chinook salmon O. tshawytscha and the
rainbow trout O. mykiss) were examined for the presence and copy num-
bers of the stat2 gene, which consistently showed as a single copy located
on chromosome 2 and 17 of the Chinook salmon and rainbow trout ge-
nome, respectively (22; Fig. 1A, 1B). A small fragment containing the start
of the stat2 open reading frame (ORF) was amplified from genomic DNA
purified from the EC cell line using the primers STAT2F and STAT2R,
purified and sequenced (see Table I). Two single guide RNAs (sgRNAs)
located in the first 50 nt of the stat2 ORF (Fig. 1C) were produced by a
combination of PCR and in vitro transcription. To identify potential off-
targets of the guide RNA, both sgRNA1 and sgRNA2 sequences were used
to search against nucleotide sequences using Blastn limited to highly
similar sequences (megablast) and restricted to entries associated with
the family “Oncorhynchus” (taxid: 8016). No off-target genes with 100%
coverage and 100% identity were identified for either sgRNA1 or sgRNA2,
suggesting high specificity of the designed guide RNAs. To generate the
sgRNA template, amplification of a 120 nt blunt-ended PCR product was
carried out using the Q5 Taq polymerase (New England Biolabs). Each
sgRNA template was amplified in five 50-ml reactions each with 25 ml
23 Q5 master mix, 400 nM DR274F forward primer (Table I), 40 nM
STAT2R1-2 reverse primer, and 20 nM template STAT2T1-2 (see Table I).
Cycling was as follows: 98˚C for 30 s then 35 cycles of 98˚C for 5 s, 60˚C
for 10 s, 72˚C for 10 s, and a final extension of 72˚C 30 s. The five re-
actions were pooled and purified using QIAquick PCR purification kit
(Qiagen) according to the manufacturer’s instructions and eluted in 50 ml
water. The sgRNAs were synthesized using the RiboMAX Express T7 kit
(Promega) purified using TRIzol (Thermo Fisher Scientific) according to
the manufacturers’ instructions. The sgRNAs were resuspended in RNAse-
and DNAse-free water and quantified by nanodrop prior to transfection.
The quality and purity of the RNAwas verified on agarose–EtBr gel before
or after RNase A treatment (Qiagen).
For transfection, the two stat2 sgRNAs were mixed with the sgRNA
targeting mEGFP and used to transfect EC cells; 100 ng of each of the
three sgRNA (two targeting stat2 and one egfp) per 10 ml of cell sus-
pension was used as described previously (21). Transfected cells were
plated onto a 75 cm2 flask and passaged weekly for 3 wk. Nonfluorescent
single trypsinized cells were then individualized by FACS onto a 48-well
tissue culture plate by a BD Influx BSLII Sorter (Iain Fraser Cytometry
Centre, University of Aberdeen) and propagated in 1 ml culture medium
for 1 mo. Four nonfluorescent clones (i.e., with mutated EGFP) were
propagated in 25 cm2 flasks and characterized further.
Genomic DNAwas purified by the HMW DNA kit and magnet (Qiagen)
according to the manufacturer’s instructions. A 306-bp segment containing
the targeted site was amplified by PCR from the genomic DNA using
primers STAT2F and STAT2R (Table I). The PCR product was purified
using QIAquick PCR purification kit (Qiagen) and directly sequenced
using the same amplification primers (Sequencing service, University
of Dundee).
All cells were grown at 22˚C in EMEM medium supplemented with
500 mg/ml G418 (Sigma-Aldrich), 30 mg/ml Hygromycin (Thermo
Fisher scientific), and 10% FBS (Nalgene).
Characterization of EC and GS2 cell lines by quantitative
RT-PCR
For the initial characterization of the response to IFN, EC and GS2 cells
were seeded into six-well plates (Greiner Bio-One). Wells were left
unstimulated or stimulated with 250 ng/ml recombinant rainbow trout
type I IFN [IFNA2; AJ582754; (23)] or 250 ng/ml rainbow trout type
II IFN [IFNG1; CAE82300; (23)] for 30 h. Recombinant IFNA2 and
IFNG1 were produced as described previously (16, 23, respectively).
Briefly, the recombinant type I and II IFN were HIS6-tagged versions of
the rainbow trout IFNA2 and IFNG1, respectively, produced under native
condition in Escherichia coli and purified under native conditions using
NiTA columns. Following the stimulation, cells were lysed by addition
of 1 ml of TRIzol (Thermo Fisher Scientific), and the total RNA was
purified according to the manufacturer’s instructions. cDNA was syn-
thesized from 500 ng of total RNA using the ABI MultiScribe reverse
transcriptase with random hexamers priming according to the manu-
facturer’s instructions (Thermo Fisher Scientific). Gene expression was
assessed by Quantitative RT-PCR (QPCR) using an LC480 real-time
PCR thermocycler (Roche) with OneTaq Hot start DNA polymerase
23 mastermix (New England Biolabs) and 503 SYBR Green (Thermo
Fisher Scientific). Primers were designed across splicing sites to exclude
amplification of genomic DNA (Table II) and verified by postamplification
analysis of the melting properties. Several QPCR products were sequenced
to verify the specificity of the assays. The elongation factor 1 a (elf1a) was
used a PCR calibrator (see Table II), and the constitutive expression of this
gene upon stimulation with type I IFN was verified by the analysis of the
RNA sequencing (RNA-seq) data.
The full ORF of O. mykiss stat2 gene (XP_021424957; O. tshawytscha
genome not available at the time) was obtained by gene synthesis (GeneArt
Gene Synthesis Service; Thermo Fisher Scientific) and subcloned into
the pcDNA3.1-Hyg expression vector between NheI and PmeI sites to
obtain an expression plasmid, pS2, expressing STAT2. A control plasmid
pcDNA3.1-Hyg-mEGFP (pG; 21) was used as a control plasmid. GS2 cells
were transiently transfected with pS2 or pG according to (21) and seeded
into six-well plates for 30 h. For each group, three wells were stim-
ulated with rIFNA2 250 ng/ml and three wells were left untreated
for 30 h, following which the cells were harvested in 600 ml of RLT buffer
(Qiagen) with 1% v/v 2-ME (Sigma-Aldrich) and stored at 280˚C until
processed. Lysate was homogenized using QIAshredder (Qiagen), and
total RNA was purified with RNeasy mini kit (Qiagen) according to
the manufacturer’s instructions. QPCR analysis was carried out as
described above.
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In a second experiment, GS2 cells were cotransfected as described above
with a transfection control plasmid (pRFP-KDEL), pmx-EGFP expressing
EGFP under the control of the rainbow trout Mx1 gene promoter obtained
by SacI/XhoI-subcloning from pGL3-Neo-Basic-pomMx1 (24; Addgene
no. 30536) into pGL4.22-Pur vector (Promega), pS2, or a control plasmid
pcDNA3.1-Hyg (pCont; Thermo Fisher Scientific). Transfected cells were
plated on a ibidi multiwell slide chamber and stimulated with rIFNA2 for
40 h at 20˚C, and the EGFP and RFP fluorescence were visualized on a
Zeiss fluorescent microscope.
Viral infection
The viral isolates used were salmon pancreatic disease virus (SPDV) isolate
F07-220, VHSV (25), and EHNV (25, 26).
For assessment of viral infection by cytopathogenic effect, EC and GS2
cells were seeded on the same 96-well plate (200 ml cell suspension per
well). Four wells were left uninfected, and for each cell line a series of
four wells were infected with serial dilutions (1–100,000) of inoculum.
The viral titer was identical for all three viral isolates and estimated to
102 PFU/ml, corresponding to a multiplicity of infection (m.o.i.) of ∼0.01
for the lowest dilution. The procedure was carried out in three sets of plates
and harvested after 3, 5, and 7 d postinfection (dpi). The quantification of
cytopathogenic effect was performed as described previously (25). Briefly,
dilutions of inoculum were incubated for different durations, the cells were
fixed, stained with crystal violet, and redissolved, and the OD at 450 nm
was read. The percentage of viral cytopathology was calculated as
100p

ODc 2ODv
ODc

, with ODc as OD of uninfected cells and ODv as OD of
infected cells.
The release of viral particles over time was measured by infecting the EC
and GS2 cell lines grown in 25 cm2 flask at the same density with EHNV
(3.1 3 105 PFU/ml ∼m.o.i. of 0.3) or VHSV (1.1 3 106 PFU/ml ∼ m.o.i.
of 0.1) and collecting supernatant after 1, 2, and 5 d. Titers of infectious
virions were measured by plaque assay on monolayers of Epithelioma
papulosum cyprini cells (EPC; ATCC CRL-2872). Collected supernatants
were serially diluted in duplicates for the plaque assay. The infection was
performed at 14˚C under a layer of methylcellulose (0.75% final concen-
tration) for 3 d after an adsorption step at 14˚C for 1 h in liquid phase. The
plaques were fixed with formaldehyde (10%), stained using crystal violet
(1% final dilution), and photographed.
Transcriptome deep sequencing analysis
IFN stimulation. For IFNA2 stimulations, two 75-cm2 flasks each for EC
and GS2 were grown to full confluency as described above. The cells were
then rinsed with Dulbecco’s PBS twice and detached with 4 ml of trypsin
per flask. The cells of the replicate flasks for each cell type where com-
bined in a falcon tube with 2 ml of Eagle’s MEM (EMEM) medium (10%
FBS) and suspended. One milliliter of each cell mix was seeded in a
25 cm2 flask to create 10 replicate flasks for each cell type. The cells were
grown to 80% confluency over 3 d at 22˚C, after which all cells were
rinsed with Dulbecco’s PBS and the excess was pipetted off. For IFNA2
stimulation, EC and GS2 cells in five replicate flasks were incubated in
25 ml of EMEM medium supplemented with 250 ng/ml of INFA2 (stock
30 mg/ml), and a further five flasks of each cell type were designated as
control cells and had 5 ml of fresh EMEM added. All flasks were incubated
for 30 h, after which RNA was extracted as described in Characterization
of EC and GS2 cell lines by quantitative RT-PCR.
Illumina library preparation and sequencing. For each of the four exper-
imental groups, three biological replicates were used for library con-
struction. The 12 RNA-Seq libraries were prepared using TruSeq Stranded
mRNA Sample Preparation Kit (Illumina) according to the manufacturer’s
instructions. Briefly, Poly-A RNAwere purified from 500 ng of total RNA
with External RNA Controls Consortium as a control using oligo(dT)
magnetic beads, fragmented, and retrotranscribed using random pri-
mers. Complementary DNAs were end-repaired and 3-adenylated; indexed
adapters were then ligated. Fifteen (15) cycles of PCR amplification were
performed, and the PCR products were cleaned up with AMPure beads
(Beckman Coulter). Libraries were validated for quality on Agilent DNA1000
Kit and quantified with the QPCR NGS Library Quantification kit (Roche).
The final libraries were pooled in equimolar amounts and sequenced in
pair-ends 2 3 75 bp on Illumina NextSeq 500/550 High Output v2 kit. For
each library, a depth 20 M reads were generated.
Mapping reads and gene expression counts. The read quality was
checked with FastQC in the ng6 environment (27). Reads were then
spliced-aligned to 47,898 genes (47,022 Gnomon, 876 RefSeq,
GCF_002163495.1_Omyk_1.0_genomic.gff from the National Center
for Biotechnology Information [NCBI]) with two additional chromosomes
harboring sequences of the pmEGFP-N1 and pcDNA3.1-Hyg-nCas9n
plasmids (28) using TopHat v2.0.14 software (29; parameters -N 2 -read-edit-
dist 2–b2-sensitive–no-coverage-search). The average number of mapped read
per sample (R1 + R2) was 5.27 million 6 0.5. Only fragments mapping
coherently and unambiguously have been considered for gene counts. Gene
counts have been assigned using featureCounts v1.5.2 (30).
Identification of differentially expressed genes
Differentially expressed genes (DEGs) between cells treated with IFNA2
and controls were identified for EC and GS2 cell lines. Additional com-
parison between EC control and GS2 control was carried out to inform on
the differential basal levels of expression between the two cell lines. DEGs
were identified using DESeq2 1.6.3 (Bioconductor) (31) and R-3.4.2 (27).
Briefly, raw counts of genes were subjected to a minimal prefiltering step;
genes for which the count sum, per group of samples, was equal or higher
than 10 in at least one group, were kept. Raw counts were normalized for
library size, and normalized data were fitted using a negative binomial
general linear model. Data were adjusted for multiple testing using the
Benjamini–Hochberg procedure (adjusted p value). Genes with an adjusted
p value , 0.01 and an absolute fold change (FC) . 2.5 or FC , 0.4 were
considered as DEGs.
Functional annotation analysis. For each rainbow trout gene (assembly
Omyk_1.0, NCBI), the longest protein model was extracted and used as a
bait for blastp analysis against the human proteome (Ab initio, Ensembl
GRCh38). The best blast hit annotations were collected (e value ,0.01).
Statistical analyses. QPCR data analysis was carried out as described
previously (23). The comparisons between experimental groups in the gene
expression levels were carried out by t test on the log-transformed levels of
expression relative to elf1a gene, followed by Bonferroni correction for
multiple comparison. The comparison between viral cytopathology levels
were carried out in a similar way after logit transformation. All variables
were considered heteroscedastic.
Results
The genome of Chinook salmon contains a single stat2 gene
TBlastn analysis of the genome assembly of O. tshawytscha
identified a unique sequence highly similar to human stat2 gene,
corresponding to the locus LOC112217577 on chromosome 2.
This gene encodes a protein (814 AA, XP_024233747) that is 42%
similar to the human STAT2 (851 AA). Single stat2 genes were
found in the other fish genomes, including other salmonids be-
longing to the genus Oncorhynchus and Salmo. These included
Atlantic salmon (Salmo salar), rainbow trout (O. mykiss), coho
salmon (O. kisutch), and Chinook salmon (O. tshawytscha), from
which derives the EC line, expressing nCas9n and mEGFP con-
stitutively (21). Only in Atlantic salmon (S. salar) have two stat2
sequences been reported (32), but only one gene is present in the
current genome assembly. Hence, only one copy of stat2 has been
retained in salmonids after the two whole genome duplications that
occurred during the early evolution of teleosts and salmonids,
respectively. All stat2 sequences from fish and tetrapods cluster in
a well-supported branch of the phylogenetic tree (Fig. 1A) that
recapitulates the tree of species, suggesting that stat2 sequences
constitute a well-supported group of orthologs. Other fish stat se-
quences are not found in this branch and group with their human
respective counterparts, indicating that the stat family had already
diversified in the common ancestor to fishes and mammals in a
similar way as irf or socs gene families (15). In keeping with this,
Chinook salmon and rainbow trout stat2 genes belong to synteny
groups partly conserved in zebrafish and human, which confirms the
orthology shown by the tree (Fig. 1B). Of note, no more additional
stat2-like sequences could be found in salmonids from the genus
Oncorhynchus, either from Whole Genome Shotgun or from
Expressed Sequence Tags databases, strongly suggesting that the
genome of this genus, indeed contain only one copy of this gene.
Production of GS2, a double mutant stat22/2 EC cell line
Following stat2- and egfp- sgRNA transfections, four nonfluo-
rescent clones (i.e., mutants in egfp) were chosen for characterization,
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propagated, and characterized. One clone was not mutated in stat2,
one had a large deletion of 42 nt (without any frame shift), one had a
silent single nucleotide substitution, and one had a 2-nt deletion
leading to a frame shift with all mutations found at the expected
site; this final clone was termed GS2. The frame shift mutation
was biallelic and homozygous; the fact that the two chromatids
were carrying the same mutation was confirmed by the purity of the
Sanger trace from direct sequencing of the purified PCR product
(Fig. 1C). The mutated ORF of the GS2 cells encodes for an 18-aa
peptide, with the first 16 residues matching the original N-terminal
of the STAT2 protein (Fig. 1C), which implies that the STAT2
functions are fully disrupted in mutant cells (Tables I–III).
Disruption of stat2 abolished the cell response to type I,
but not II, IFN
The expression of a number of key ISGs (mx, irf1, dhx58, pkr, and
ifna3) were measured by real-time QPCR following stimulation
with IFNA2 (Fig. 2A) or IFNG1 (Fig. 2B). After stimulation with
the type I IFN IFNA2, a typical response of these typical ISGs was
observed in the EC cells but was abolished in the GS2 cells, as
shown by the lack of significant induction of mx, irf1, dhx58, and
pkr genes (Fig. 2A). After stimulation with type II IFN (IFNG1),
the induction profile in EC cells was different, with no significant
induction of mx gene but a very potent and significant induction
of irf1 gene (Fig. 2B). Interestingly, ifna3 was also significantly
induced by IFNG1, in addition to dhx58 and pkr (Fig. 2B). In GS2
cells, the induction level of all tested genes but mx remained
significant, but was somewhat reduced compared with EC, sug-
gesting a possible role of STAT2 in their expression. Importantly,
the induction of irf1 remained very high in GS2, with an FC of
26.8. Stimulated levels of irf1 induction were not significantly
different between EC and GS2. Overall, our data indicate that the
induction of typical ISGs by type I IFN (IFNA2) in EC cells is
abolished in GS2 cells, whereas the response to type II IFN (IFNG1)
remains significant in both cell lines.
Additionally, using a stat1a12/2 stat1a22/2 cell line (GS1A)
obtained using the same procedure than GS2 (Supplemental Fig. 1),
we showed that these mutations abolished all upregulation of mx,
irf1, dhx58, and ifna3 genes either by IFNA2 or by IFNG1 (Fig. 2C,
2D). Importantly, although irf1 was significantly induced (1462 6
269-fold; p , 0.01) in the EC cell line or in the GS2 line, it was
not upregulated in GS1A cells (0.5 6 0.1-fold; p = 0.42; Fig. 2D),
indicating that the response to type II IFN was also affected in this
case.
These conclusions based on gene expression in GS2 cells 30 h
poststimulation with IFNA2 or IFNG1 were confirmed on a time
course of induction 6, 24, and 48 h after addition of rIFNA2 or
IFNG1 (Fig. 2E–G). Only irf1—but not mx nor ifna3—was signif-
icantly induced in the GS2 cell line after IFNG1 stimulation for 6,
24, or 48 h, corroborating the abolishment of IFNA2 but not IFNG1
signaling in the stat22/2 cells and the irf1 status as a marker for
type II IFN activity.
To verify that the modifications in IFN signaling are due to the
mutation in stat-2, we transfected GS2 cells with a stat2 expres-
sion plasmid and tested the effect of 30 h IFNA2 stimulation. As
shown in Fig. 3A, the induction was 3.6- and 2.2-fold for mx and
irf1 genes, respectively, showing a significant restoration of Stat2
function. This was verified at the cellular level by the activation of
a reporter system in transfected cells when STAT2 was provided
by an expression plasmid after stimulation with rIFNA2. In trans-
fected cells (positive for RFP), GFP was higher than the auto-
fluorescence background only when GS2 cells were cotransfected
with the pS2 plasmid expressing STAT2, demonstrating the restoration
of the IFNA2 signaling pathway (Fig. 3B).
FIGURE 1. Genomic structure of the stat1 and stat2 loci in salmonid fish. (A) Phylogenetic tree of Stat1 and Stat2 in rainbow trout and Chinook salmon.
The evolutionary history was inferred using the neighbor-joining method. The bootstrap consensus tree inferred from 500 replicates is taken to represent the
evolutionary history of the taxa analyzed. Branches corresponding to partitions reproduced in ,50% bootstrap replicates are collapsed. The percentage of
replicate trees in which the associated taxa clustered together in the bootstrap test (500 replicates) are shown next to the branches. The evolutionary
distances were computed using the JTT matrix-based method and are in the units of the number of amino acid substitutions per site. The rate variation
among sites was modeled with a g distribution (shape parameter = 1). (B) Synteny analysis of the stat2 locus in Chinook salmon, rainbow trout, zebrafish,
and human. (C) Location of the two sgRNA (represented in pink by ####) and chromatogram obtained from direct sequencing of purified PCR product
amplified from genomic DNA purified from GS2 cells. The intronic and exonic sequences are in lower and upper case, respectively. The intron 1 acceptor
site is in gray, and the protospacers are in cyan. The 2-nt deletion is highlighted in green, the start and premature stop codons are in red.
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Whole transcriptome analysis shows that the response to type I
IFN (IFNA2) is almost fully abolished in GS2 cells
To achieve a global overview of the transcriptional response be-
tween EC and GS2 cells, the whole transcriptome was analyzed
by Illumina deep sequencing (RNA-seq) with or without stimu-
lation for 24 h with IFNA2. The dataset has been submitted to NCBI
under the BioProject 495492. The RNA-seq mapping showed 30,536
unique loci were identified when aligned to the rainbow trout
genome; of these, 27,972 were annotated as producing a func-
tional protein. Expression changes of the 40 genes most induced
by IFNA2 in EC are represented as a heatmap in Fig. 4, with 35
of them (88%) present in the Interferome database (33). None of
these genes were found significantly induced in GS2 (Fig. 4),
indicating a general breakdown of the ISG response to IFNA2.
Genes upregulated by IFNA2 with an FC .5 in EC, but not in
GS2, included several typical and well-conserved ISG such
as vtcn1, mx3, ifit5, helz2, stat1b1, cd9, and ifi27 (4, 15). A full
table of genes significantly modulated by IFNA2 is shown in
Supplemental Table I. In total, 34 genes were significantly induced
more than 2.5-fold in the parental cells (EC) (51 genes more than
2-fold) when stimulated with IFNA2, whereas only a single gene
was downregulated,0.4-fold (Supplemental Fig. 2, Supplemental
Table I). In contrast, only two genes were significantly increased
.2.5-fold in GS2 cells upon IFNA2 stimulation (44 genes more
than 2-fold), with four genes decreased in expression ,0.4-fold
(16 ,0.5-fold). A logFC/logFC representation of the differential
response of EC and GS2 cells is shown in Supplemental Fig. 2A,
2B, highlighting the lack of highly induced genes in GS2. To
further characterize the responses of EC and GS2 cells, we used
both gene ontology (biological process) enrichment analysis and
KEGG pathway analysis to identify the main functional groups
that were enriched upon IFNA2 stimulation (Supplemental
Fig. 2C). Results from this analysis showed a clear differ-
ence between the cell lines. The enrichment of biological
processes in EC cells was significant for the Gene Ontology
(GO) identifier “defense response to virus” (Benjamini corrected
e value,5%), whereas the GO enriched biological process in GS2
was “Platelet aggregation” with the KEGG pathway “Regulation
of actin cytoskeleton,” which did not evoke a link with the IFN-based
antiviral response.
Interestingly, there were 224 (up) 178 (down) genes signifi-
cantly altered between nonstimulated EC and nonstimulated
GS2 cells (Supplemental Table II), suggesting that changes are
induced by the Stat2 knockdown; however, these were not signifi-
cantly enriched for GO functional terms related to IFN or antiviral
activity.
The level of expression of stat1 and stat2 as measured by deep
sequencing showed that only the stat1b1 paralogue and stat2 were
found upregulated in EC, and neither in GS2, corresponding to the
6th and 37th genes in Fig. 4, respectively.
For further examination of the RNA-seq data, confirmation of the
expression of the genes encoded by the stable transfected plasmids
was made. The transcripts count mapped to the Cas9 expression
plasmid was 42,387 and 18,437 for EC and GS2, respectively. The
counts of transcripts mapped to mEGFP expression plasmid was
192,847 and 13 for EC and GS2, respectively, indicating a 99.99%
reduction in the abundance of mEGFP transcripts in the GS2 cells
related to EC. The transcript count for elf1a, which we used as
house-keeping gene for QPCR, was 72,016 and 76,357 for EC and
GS2, respectively. Interestingly, the mEGFP transcript count was
the highest recorded value for any of the 30,535 mapped tran-
scripts in any of the samples analyzed and may be a contributor to
the transcriptional activity differences between the EC and GS2
control cells.
Moderate modification of the sensitivity of GS2 cells to
viral infection
For SPDV, EHNV, and VHSV, the cytopathic effect was signifi-
cantly higher in GS2 than in EC cells; for SPDV this was observed
at 5 and 7 dpi, for EHNVat 3 and 5 dpi, andVHSVwas only increased
at 3 dpi (Fig. 5A–C). At 7 dpi, the maximum increase in percentage
of cytopathology in GS2 was for VHSV, with 33.9 6 17.5% in EC
and 43.5 6 21.9% in GS2, but the difference was not significant.
At 7 dpi, the only consistent significant, but minimal, increase was
for SPDV, for which the percentage cytopathology was 81.2 6
1.5% in EC and 83.4 6 0.7% in GS2.
Table II. Primers used for QPCR gene expression
Gene Sequence 59-39 Forward Sequence 59-39 Reverse Accession Number
mx 59-GATGCTGCACCTCAAGTCCTATTA-39 59-CGGATCACCATGGGAATCTGA-39 mx1 XM_024415949;
mx3 XM_024415945
pkr 59-GAAAACCTTCACTCTGAGGG-39 59-GACATGAAACCGATGCATCC-39 XM_024425247
dhx58 59-GCTGGTCAACAAGGTTCATTTGGTTG-39 59-GCAGAGTGAACTGTGAGAGC-39 XM_024390155
irf1 59-TTCTACACATCTTTCCAAGTGTCA-39 59-GGGTTTCTTGGTGACTGTCTT-39 XM_024432485
ifna3 59-ACTGAAACGCTACTTCAAGAAGTTGA-39 59-GCAGATTATGTTTCGTCTCTTTCCT-39 XM_024434108
stat2 59-CCCCACCGGTGAGCCTGATG-39 59-GACTATCCGCTCCACTCTTCT-39 XM_024377979
elf1a 59-CCCCTCCAGGATGTTTACAAA-39 59-CACACGGCCCACGGGTACA-39 XM_024441752
Table I. Primers used for the characterization of the targeted site and for the synthesis of sgRNAs
Name Sequence Use
STAT2F 59-GTGGTCAGACCACTGGCAGC-39 Sequencing sgRNAs stat2 locus
STAT2R 59-GGATGAGTGGACTGCCTCACC-39
STAT2T1 59-AAAAGCACCGACTCGGTGCCACTTTTTCAAGTTGATAACGGACTAGCCTT
ATTTTAACTTGCTATTTCTAGCTCTAAAACCTGTGCCATGCCTGGCTGAA-39
Production of the stat2 sgRNA1
STAT2R1 59-AGCTAATACGACTCACTATATTCAGCCAGGCATGGCACAG-39
STAT2T2 59-AAAAGCACCGACTCGGTGCCACTTTTTCAAGTTGATAACGGACTAGCCTT
ATTTTAACTTGCTATTTCTAGCTCTAAAACGTGTCAGGTACACAGACTCC-39
Production of the stat2 sgRNA2
STAT2R2 59-AGCTAATACGACTCACTATAGGAGTCTGTGTACCTGACAC-39
DR274F 59-AAAAGCACCGACTCGGTGCCAC-39 Production of stat1 and stat2 sgRNAs
The target for sgRNAs are underlined.
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The titrations of EHNVat 2 dpi and VHSVat 5 dpi from EC and
GS2 supernatants are shown in Fig. 5D, 5E, respectively. Clear
signs of EHNV infection with visible plaques were seen for the
GS2 cell line up to dilution 104–105, but no signs were visible for
the EC cell line supernatant at any dilution (Fig. 5D). Similar
results were seen with supernatant collected at dpi 1 and 2 (data
Table III. Summary of the levels of expression and induction of the stat1 and stat2 genes as measured by RNA-seq in EC and GS2 following stimulation
with IFNA2
Accession Number (GeneID NCBI) Adjusted p Value (FC)
Name O. mykiss O. tshawytscha EC ifn, EC control GS2 ifn, GS2 control EC control, GS2 control
stat 1a1 NP_001118179 (GeneID 100136755a) LOC112266551b,
LOC112253955b
NS NS NS
stat 1a2 XP_021463912 (GeneID 100137016a) LOC112253897b,
LOC112253778b
NS NS NS
stat 1b1 XP_021434868 (LOC110501544) LOC112244575 ,0.0001 (10.6) NS NS
stat 1b2 XP_021452654 (LOC110520020) LOC112235369 NS NS NS
stat 2 XP_021424956 (LOC110494323) LOC112217577 ,0.0001 (2.1) NS ,0.0001 (1.8)
aProvisional RefSeq status as of 13th March 2019.
bDuplication due to assembly errors in the O. tshawytscha genome as of March 13, 2019.
FIGURE 2. Gene expression in EC and GS2 cell line after IFNA2 or IFNG1 stimulation. Expression levels of ISGs mx, irf1, dhx58, and ifna3 ISGs
measured by QPCR in EC and GS2 cell lines after 30 h induction with recombinant rainbow trout type I (IFNA2) (A) or type II (IFNG1) (B) IFN. Ex-
pression levels of ISGs mx, irf1, dhx58, and ifna3 ISGs measured by QPCR in EC and GS1A cell lines after 30 h induction with recombinant rainbow trout
type 1 (IFNA2) (C) or type II (IFNG1) (D) IFN. The GS1A cell line has been obtained using a similar approach than GS2 (Supplemental Fig. 1) * indicates
level of significance of the fold increase versus corresponding control. Kinetics of induction of mx (E), irf1 (F), and ifna3 (G) genes in EC or GS2 cells after
6, 24, or 48 h stimulation with IFNA2 (IFNA) or IFNG1 (IFN-g). Data represent average FC (n = 3) relative to the corresponding unstimulated control.
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not shown). No clear differences could be observed in the viral
titer of supernatant collected after VHSV infection with signs of
infection in both cell lines (Fig. 5E).
Discussion
Type I IFN are central to the host defense against viruses and are
believed to activate via a conserved Jak/Stat signaling pathway.
As part of our effort to unravel the detailed IFN signaling
mechanisms in cells from a genome-duplicated lower verte-
brate, we demonstrate for the first time, to our knowledge, that
Stat2 is an obligatory player in type I IFN signaling, con-
firming that this pathway is conserved between teleosts and
mammals.
Workflow for salmonid knockout cell lines
The present work demonstrates a robust approach to generate a
knockout somatic salmonid fish cell line with a high efficiency
by using a fluorescent reporter transgene as a screening cotarget
(21). The parental cell line, EC, constitutively expressing a
functional nuclear nCas9n and monomeric mEGFP, is tran-
siently transfected with a mix of sgRNAs designed against
the gene of interest (stat2 in this study) and against megfp.
mEGFP-deficient single cells are isolated by FACS and left to
propagate into clonal cell lines. Because of the slow growth of
fish cells, the timeline for the isolation of such a cell line was
∼3 mo from the initial sgRNA transfection to the isolation of
clonal cell lines, with sufficient material to characterize its
genotype and its phenotype by PCR sequencing and QPCR,
respectively.
The target gene stat2 was present as a single copy in the
genomes of rainbow trout, coho salmon, and Chinook salmon.
The current assembly of the Atlantic salmon S. salar genome
also contains a single copy of the stat2 gene. From the RNA-seq
data, only one stat2 transcript could be detected in the EC cell
line with or without IFNA2 induction, confirming the in silico
analyses. In contrast, there were four paralogs of stat1. Two
copies were closely related to the zebrafish stat1a gene that was
not induced by Chikungunya infection, and two copies corre-
sponding to stat1b, which was significantly upregulated (15). In
the current study, out of the four mEGFP-deficient clones iso-
lated, and three were mutated in the targeted gene stat2, with
one of them being a null mutant. Besides the successful mul-
tiplex gene editing, it is remarkable that all three clones isolated
were carrying homozygote biallelic mutations on the stat2 locus
similarly to results obtained in previous studies in mouse em-
bryonic stem cells (34, 35) or in embryos of other fish species
or in agnathans [Zebrafish (36); Lamprey (37); Medaka (38);
Salmon (39)]. In somatic cells, the exact mechanism by which
Cas9 induces homozygote biallelic mutation is currently unknown.
It is important to have in mind that the cotargeted locus, megfp, in
the EC cell line is a transgene with an uncharacterized site(s) of
genomic integration.
The IFNA2 inducibility was partially restored by transfec-
tion of GS2 cells with a STAT2 expression plasmid. The rescue
of stat2 function was carried out by transfection with an ex-
pression plasmid. Because fish cell lines are traditionally dif-
ficult to transfect, only a small percentage of GS2 cells had their
STAT2 function restored, and the vast majority of cell were
untransfected and still deficient in IFN signaling. By cotrans-
fection with a reporter system, the GS2 rescue could be visu-
alized at the cellular level when STAT2 was expressed and IFN
present.
FIGURE 3. Restoration of STAT2 function in GS2
cells. (A) Gene expression levels of mx and irf1 in GS2
cells that were transfected with plasmids overexpressing
either mEGFP (pG) or Stat2 (pS2) after 24 h. The results
are presented related to the pG group and therefore show
the fold increase (*p , 0.05, n = 3). (B) Fluorescence of
GS2 cells cotransfected with pRFP-KDEL (transfection
control), pmx-EGFP (reporter for IFN activation), pS2
(rescue plasmid expressing STAT2), or pCont (empty
vector) after 40 h stimulation with rIFNA2.
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Strong nonsense-mediated mRNA decay for egfp but not stat2
in GS2 cell line
The expression level of the stat2 mRNAwas not affected by the
null mutation, suggesting that its transcript is resistant to the
nonsense-mediated mRNA decay (NMD). This was expected,
as in the corresponding mutated stat2 mRNA the premature
termination codon is close to the 59 untranslated region and
would escape NMD destruction (40, 41). In contrast, there was a
99.99% decrease in the megfp transcript abundance in the GS2
relative to EC cells. This result is surprising, as the mEGFP
transgene is intronless (21) and as such, according to some NMD
models, is thought to be immune to the NMD pathway (42). In
this context, the marked difference in the NMD sensitivity of
the stat2 and egfp transcripts in GS2 cells is interesting and may
suggest an alternative NMD model (43) or a peculiar NMD
mechanism in fish, as highlighted in immune cells producing Ig
and TCR transcripts (44).
Stat2 knockout affects type I but not type II IFN
signaling pathway
The initial characterization of the type I IFN–induction phenotype
by QPCR after incubation with recombinant type I IFN showed a
general disruption of ISGs induction in the GS2 cell line. This was
confirmed by the overall transcriptome analysis by RNA-seq.
In a human fibrosarcoma cell line, IRF 1 (irf1) has been found to
be induced substantially only by type II IFN (45),and a strong
modulation of this transcript is now considered as a hallmark of
Stat1 dimer signaling/GAS-specific ISG (46). Our results showed
FIGURE 4. Whole transcriptome analysis of
EC and GS2 cells after IFNA2 stimulation. List
of the most inducible genes in the EC cell line
after incubation with 30 h IFNA2 as deter-
mined by whole transcriptome sequencing. The
heatmap represents the FC between control and
induced conditions for the EC cell lines or the
GS2 cell line, or between EC control and GS2
control cells. A complete list of genes signifi-
cantly modulated by IFNA2 in EC and GS2
cells is provided in Supplemental Table I.
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that fish irf1 gene was very strongly induced by IFNG1 but not by
IFNA2 in the parental cell line EC, which supported that irf1 is a
good marker of the type II IFN response as in mammals. In GS2
cell lines, irf1 gene was strongly induced as in the parental cell
line, indicating that irf1 induction does not rely on stat2 signaling.
Similar results were reported in primary embryonic fibroblast cells
isolated from stat2 knockout mice (47). In contrast, the GS1A cell
line with deficient stat1a1 and stat1a2 genes had both IFNA2 and
IFNG1 pathways disrupted. This was particularly clear with irf1,
strongly induced after stimulation with IFNG1 in EC but not in
GS1A (Fig. 2C, 2D), confirming that the signaling for IFNA2 is
impacted by Stat1A proteins.
pkr, mx, or dhx58 are type I IFN–specific ISGs (48), and their
induction by IFNA2 was completely abolished in the GS2 cell line
in comparison with the parental EC cell line. Similarly, primary
kidney cells isolated from stat2 knockout hamsters were unable to
induce pkr after incubation with IFN-a (49).
These results demonstrate that in salmonid cells, Stat2 is
involved essentially in the signaling pathway of type I IFN in
agreement with the canonical mammalian model for the IFN
signaling (50), whereas it is not required for type II IFN signaling.
Thus, our results support a model in which fish type II IFN signals
by Stat1:Stat1 dimers, whereas type I IFN signals by the ISGF3, a
Stat2:Stat1:IRF9 heterotrimer (2). Although we observed a mod-
erate induction of dhx58 and pkr by rIFNG1 in EC cells, it was
likely an indirect effect due to the modest upregulation of type I
IFN by this treatment. The abolition of these effects in GS2
would therefore be consistent with the canonical model men-
tioned above.
Similar results were published in mammalian stat2 knockout
models such as primary culture of peritoneal macrophages har-
vested from stat2 knockout mice (47) or the human U6A cell line
(51). In NB4 cells (human acute promyelocytic leukemia cells),
irf1 gene is induced more intensively by type II than type I IFN
(52) and follows the same pattern of expression than in EC cells.
Viral sensitivity
Although the IFNA2 signaling pathways were completely abol-
ished, the GS2 cell line exhibited notable elevation in the per-
centage viral cytopathology that was observed at the early stage of
infection following infection with SPDV, EHNV, or VHSVat 15˚C.
This variation in the kinetics of infection between EC and GS2
cell lines may not be more remarkable than differences that would
be observed between two clonal cell lines from the same origin
(53, 54). However, if the viral cytopathology was mainly linked to
the induction of Stat2-dependent ISGs, we would have observed a
more pronounced alteration of the effect of viral infection in GS2
cells in comparison with EC cells.
The amount viral particles produced at early stage of in-
fection with EHNV, a DNA virus, is higher in GS2 than in EC
and is coherent with an increase of cytopathology with this
virus. However, the results are different with VHSV, a negative
FIGURE 5. Percentage of viral cytopathogenicity after 3-, 5-, or 7-d infection and viral titer in EC and GS2 cell lines. Viral cytopathology measured
postinfection with EHNV (A), SPDV (B), and VHSV (C). Visualization of the viral titer determined on EPC cells in supernatant from EC or GS2 cells
infected with EHNV for 2 d (D) or VHSV for 5 d (E).
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ssRNA virus, whereby GS2 cells produce less viral particles.
Replication of EHNV was found to be very sensitive to the level of
ISG15 in cyprinid cells (55) and only mildly to the presence of Mx1
protein in salmonid cells (25). The absence of induction of these
genes in GS2 may therefore explain, although partially, the increased
viral cytopathy and shedding in the cell line.
This contrasted with results in mice where infection with vesicular
stomatitis virus of primary or immortalized fibroblast cultures isolated
from stat2 knockout mice exhibited viral titers increased up 80- and
20-fold relative to wild type, respectively (47).
From the RNA-seq data, following stimulation with IFNA2,
a discrete number of ISGs were induced significantly in both
EC and GS2 cell lines. As an example, two of them, guanine
nucleotide-binding protein G subunit a-like (GNAI) and glu-
tathione peroxidase 1 (GPX-1), were induced over 2-fold in
both cell lines after stimulation with IFNA2. The latter have
been associated with viral sensitivity (56) and may explain, at
least partially, the GS2 viral resistance. Further functional
characterization of such genes may reveal important roles in
the Stat2-independent antiviral activity.
Possible role of IRF1-regulated genes in antiviral resistance at
the cellular level
The induction of ISGs via alternative pathway(s) can be possible
without the involvement of either Stat1 or Stat2 as described in
West Nile virus Eg101–infected mouse cells (57). These results are
in agreement a previous study (58) whereby surviving patients
with deficient type I IFN pathway caused by Stat2 null phenotype
are remarkably healthy with no evident impairment in their innate
immunity. However, other reports may suggest different conse-
quences of disappearance of Stat2 in other species. Approximately
40% of hamsters lacking Stat2 succumbs to Zika virus (59);
however, in this study, there was no side-by-side comparison with
the wild type.
In human, Schoggins et al. (4) reported that IRF1 inhibited
many viruses, including hepatitis C virus, HIV-1, yellow fever
virus, West Nile virus, Venezuelan equine encephalitis virus,
and chikungunya virus, even in a stat12/2 background, indi-
cating that this transcription factor triggers a particular antiviral
pathway. In fact, IRF1 overexpression in Stat12/2 fibroblasts
upregulated the expression of many well-known ISGs and ef-
fector proteins such as Mx1, IFI-6, -27, -30, -35, and 44, IFIT1
and 3, and ISG15, IRF9, SAMD9, USP18, and ISG20 but not type
I IFN. Thus, the repertoire of IRF1 induced genes only partly
overlaps the typical set of ISGs induced via IFNR and Jak/Stat.
Overall, our QPCR and whole transcriptome data suggest that
the irf1 expression in GS2 is not sufficient to rescue a detectable
induction of ISGs. Thus, a number of fish orthologs of ISGs in-
ducible by IRF1 overexpression in human Stat12/2 fibroblasts
were induced by trout IFNA2 in EC but not in GS2. These genes
included mx1, ifi27, ifi44, gbp1, lgals3BP, parp14, usp18, samd9l,
dhx58, ifit5, and zc3hav1. In fact, no gene significantly induced
by type I IFN in GS2 was orthologous to a member of the IRF1-
stimulated gene list reported previously (60). Overall, these results
indicate that the faint (and nonsignificant) irf1 induction observed
in GS2 after type I IFN stimulation does not complement the
disruption of the Stat2 dependent signaling.
We have demonstrated that the function of Stat2 in salmonid
cells follows the canonical signaling pathway described in higher
vertebrates. However, the effect of the Stat2 loss of function on the
ability to resist to a viral infection depends on the type of virus.
Further transcriptomics studies on the GS2 cell line upon early
infection with different categories of viruses are required to identify
genes responsible for viral resistance.
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